Covid-19 roundup: Inovio finally gets PhII rolling — but there's still a clinical hold; Low cost vaccine enters PhI/II in India
Inovio has managed to convince the FDA to sign off on a Phase II trial of its Covid-19 vaccine. But the Phase III portion remains …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
